文献速递肝病消化道肿瘤与早癌

白细胞介素6介导的炎症环路将转化生长因子β缺陷的β2-血影蛋白+/-小鼠癌前肝脏中的正常干细胞重编程为上皮-间质转化+转移性癌症干细胞

IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient β2-spectrin+/- mice.
PubMed 文献 · Hepatology · 2017-01-20

研究在野生型和β2-血影蛋白(SPTBN1)+/-小鼠中建立慢性炎症模型,发现来自白细胞介素6处理的β2SP+/-小鼠癌前肝脏的CD133+肝干细胞具有高致瘤性和转移性,而野生型来源细胞无致瘤性。机制上,IL6通过TAK1-NFκB信号通路组成性激活NFκB,与缺陷的TGFβ信号协同促进正常肝干细胞向转移性癌症干细胞转化。

要点

  • IL6处理的β2SP+/-小鼠癌前肝脏CD133+肝干细胞高致瘤且转移,野生型来源者无致瘤性。
  • IL6 β2SP+/-肝干细胞中Twist和Slug核定位,NFκB组成性激活,敲低NFκB降低上皮-间质转化表型和转移能力。
  • NFκB由TAK1激活,人正常、肝硬化至肝癌组织中组成性激活NFκB量显著增加。

核心结论

  • IL6介导的炎症在CD133+肝干细胞中程序化组成性激活TAK1-NFκB信号级联,并与缺陷的TGFβ信号相互作用,加速正常肝干细胞向转移性癌症干细胞转化。

研究设计与样本

  • 研究在野生型和β2-血影蛋白(β2SP)+/-(SPTBN1)小鼠中建立慢性炎症模型,比较IL6处理的β2SP+/-与野生型小鼠来源的CD133+肝干细胞的致瘤性和转移能力。

主要发现

  • 来自IL6处理的β2SP+/-小鼠癌前肝脏的CD133+肝干细胞(IL6 β2SP+/- LSCs)高度致瘤且转移,而来自IL6处理的野生型小鼠的CD133+肝干细胞(IL6 WT LSCs)增殖显著较少且无致瘤特性。
  • IL6 β2SP+/- LSCs exhibit核内Twist和Slug(上皮-间质转化标志物)定位,并组成性激活核因子κB(NFκB;RELA)。
  • 敲低NFκB降低了IL6 β2SP+/- LSCs的上皮-间质转化表型和转移能力。
  • IL6 β2SP+/- LSCs中的NFκB由转化生长因子β激活激酶1(TAK1;MAP3K7)激活,TAK1与肝癌患者生存差及白细胞介素6(IL6)表达相关。
  • 人正常、肝硬化和肝癌组织中组成性激活NFκB的量显著增加。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Hepatocellular carcinoma (HCC) is the second-leading cause of cancer-related deaths worldwide with a poor survival rate. As many as 40% of HCCs are clonal, with alteration of key tumor-suppressor pathways in stem cells as the primary cause of HCC initiation. However, mechanisms that generate metastatic stem cells in preneoplastic liver tissue are not well understood. We hypothesized that chronic inflammation is a major driver of the transformation of genetically defective liver stem cells (LSCs) into highly metastatic liver cancer cells in premalignant liver tissue. We developed models of chronic inflammation in wild-type (WT) and β2-spectrin (β2SP)+/- (SPTBN1) mice. CD133+ LSCs derived from preneoplastic livers of β2SP+/- mice treated with interleukin-6 (pIL6; IL6 β2SP+/- LSCs) were highly tumorigenic and metastatic, whereas those derived from WT mice treated with pIL6 (IL6 WT LSCs) had significantly less proliferation and no tumorigenic properties. IL6 β2SP+/- LSCs not only exhibited nuclear localization of Twist and Slug, markers of epithelial-mesenchymal transition (EMT), but also constitutive activation of nuclear factor kappa B (NFκB; RELA). Knockdown of NFκB decreased the EMT phenotypes and metastatic capacity of these cells. NFκB in IL6 β2SP+/- LSCs was activated by transforming growth factor β (TGFβ)-activated kinase 1 (TAK1; MAP3K7), which is associated with poor survival in HCC and interleukin-6 (IL6) expression. The amount of constitutively activated NFκB increased dramatically from normal to cirrhotic to HCC tissues from human patients. CONCLUSION: IL6-mediated inflammation programs constitutive activation of the TAK1-NFκB signaling cascade in CD133+ LSCs, and this program interacts with deficient TGFβ signaling, thereby accelerating the transformation of normal LSCs to metastatic cancer stem cells (mCSCs). Indeed, this study delineates the development of EMT-positive mCSCs in HCC-free liver tissue upon chronic inflammation. (Hepatology 2017;65:1222-1236).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Mitra A, Yan J, Xia X, et al. IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient β2-spectrin+/- mice. Hepatology. 2017. PMID: 27863449. doi:10.1002/hep.28951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。